On 21st July 2022, Pacific Edge announced that it had substantially completed a commercial agreement with Te Whatu Ora – Southern for the use of its Cxbladder genomic biomarker tests.
The contract is yet to be signed and is currently being reviewed by Te Whatu Ora – Southern Management Team, following which it will enter an approvals cycle.
See more
The S&P/NZX 50 Index rose 97.07 points, or 0.8%, to 12,447.68.
Fletcher Building subsidiary Iplex Australia to cover 80% of repair costs.
The bus operator's net loss widened from $8m to $17m in the year to March 31.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details
